nach oben

European Archives of Oto-Rhino-Laryngology

Erschienen in:

17.12.2018 | Head & Neck

Outcome of patients following neo-adjuvant chemotherapy for unresectable cervical nodes in head and neck squamous cell carcinomas

verfasst von: Akshat Malik, Burhanuddin N. Qayyumi, Manish Mair, Hitesh Singhavi, Yash Mathur, Deepa Nair, Sarbani Ghosh-Laskar, Jai Prakash Agrawal, Kumar Prabash, Pankaj Chaturvedi

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

This study was undertaken to assess the effects of neo-adjuvant chemotherapy (NACT) on patients with head and neck squamous cell carcinoma (HNSCC) having advanced unresectable cervical nodal metastasis.

Methodology

A retrospective cohort study was conducted to assess the response of unresectable nodes to NACT in a pragmatic manner. Patients were grouped according to the response noted and the treatment offered after chemotherapy. The median survival amongst the patients in these groups was compared.

Results

The study included 51 patients. Oral cavity was the commonest site (67.2%). Favourable nodal response was seen in 64.7% of the patients. Up to 87.9% of the nodal responders were amenable to curative intent therapy. The overall survival of patients undergoing surgery, definitive chemoradiotherapy, palliative chemotherapy and palliative radiotherapy was 24, 13, 10 and 9 months, respectively.

Conclusion

NACT may be utilized in HNSCC with advanced inoperable nodal disease to make them amenable to definitive therapy.

Forastiere AA, Ang KK, Brizel D et al (2008) Head and neck cancers. J Natl Compr Canc Netw 6:646–695CrossRefPubMed

Gyawali B, Shimokata T, Honda K, Ando Y (2016) Chemotherapy in locally advanced head and neck squamous cell carcinoma. Cancer Treat Rev 44:10–16CrossRefPubMed

Lefebvre J-L, Andry G, Chevalier D, Luboinski B, Collette L, Traissac L et al (2012) Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891. Ann Oncol Oct 23(10):2708–14CrossRef

Haddad R, O’Neill A, Rabinowits G, Tishler R, Khuri F, Adkins D et al (2013) Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. Lancet Oncol 14(3):257–264CrossRefPubMed

Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M et al (2007) Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357(17):1695–1704CrossRefPubMed

Patil VM, Prabhash K, Noronha V, Joshi A, Muddu V, Dhumal S et al (2014) Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers. Oral Oncol 50(10):1000–1004CrossRefPubMed

Patil V, Noronha V, Joshi A et al (2013) Is there a limitation of RECIST criteria in prediction of pathological response, in head and neck cancers, to post induction chemotherapy? ISRN Oncol 2013:259154PubMedPubMedCentral

Wolf GT, Fisher SG, Hong WK, Hillman R, Spaulding M, Laramore GE et al (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685–1690CrossRefPubMed

Forastiere AA, Zhang Q, Weber RS, Maor MH, Goepfert H, Pajak TF et al (2013) Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 31(7):845–852CrossRefPubMed

10.

Licitra L, Grandi C, Guzzo M, Mariani L, Lo Vullo S, Valvo F et al (2003) Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial. J Clin Oncol 21(2):327–33CrossRefPubMed

11.

Zhong L, Zhang C, Ren G, Guo W, William WN, Sun J et al (2013) Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. J Clin Oncol 31(6):744–751CrossRefPubMed

12.

Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V et al (2007) Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357:170–175CrossRef

13.

Ma J, Liu Y, Yang X, Zhang C, Zhang Z, Zhong L (2013) Induction chemotherapy in patients with resectable head and neck squamous cell carcinoma: a meta-analysis. World J Surg Oncol 11:67CrossRefPubMedPubMedCentral

14.

Ghi MG, Paccagnella A, Ferrari D, Foa P, Alterio D, Codecà C et al (2017) Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II–III trial. Ann Oncol 28(9):2206–2212PubMed

15.

Patil VM, Muttath G, Babu S, Kumar ST, Jones J, Sen S et al (2015) Does the use of induction chemotherapy in oral cavity cancer compromise subsequent loco-regional treatment delivery: results from a matched pair analysis. Indian J Cancer 52(4):632–636CrossRefPubMed

16.

Zhong L, Zhang C, Ren G, Guo W, William WN, Hong CS et al (2015) Long-term results of a randomized phase III trial of TPF induction chemotherapy followed by surgery and radiation in locally advanced oral squamous cell carcinoma. Oncotarget 6(21):18707–18714CrossRefPubMedPubMedCentral

17.

Nishikawa D, Hanai N, Ozawa T, Hirakawa H, Suzuki H, Nakashima T et al (2015) Role of induction chemotherapy for N3 head and neck squamous cell carcinoma. Auris Nasus Larynx 42(2):150–155CrossRefPubMed

18.

Cohen EEW, Karrison TG, Kocherginsky M, Mueller J, Egan R, Huang CH et al (2014) Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer. J Clin Oncol 32(25):2735–2743CrossRefPubMedPubMedCentral

19.

Fletcher GH (1972) Elective irradiation of subclinical disease in cancers of the head and neck. Cancer 29(6):1450–1454CrossRefPubMed

20.

Bataini JP, Bernier J, Asselain B et al (1988) Primary radiotherapy of squamous cell carcinoma of the oropharynx and pharyngolarynx: tentative multivariate modelling system to predict the radiocurability of neck nodes. Int J Radiat Oncol Biol Phys 14(4):635–642CrossRefPubMed

21.

Argiris A, Stenson KM, Brockstein BE et al (2004) Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 26(5):447–455CrossRefPubMed

22.

Machtay M, Moughan J, Trotti A et al (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26(21):3582–3589. https://doi.org/10.1200/JCO.2007.14.8841 CrossRefPubMedPubMedCentral

23.

Taylor JM, Mendenhall WM, Parsons JT et al (1992) The influence of dose and time on wound complications following post-radiation neck dissection. Int J Radiat Oncol Biol Phys 23(1):41–46CrossRefPubMed

24.

Schwartz LH, Litière S, de Vries E, Ford R, Gwyther S, Mandrekar S et al (2016) RECIST 1.1—update and clarification: from the RECIST Committee. Eur J Cancer 62:132–137CrossRefPubMedPubMedCentral

25.

Ko HC, Chen S, Wieland AM et al (2017) Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: analysis of the National Cancer Database. Head Neck 39:2159–2170CrossRefPubMedPubMedCentral

26.

Smyth JK, Deal AM, Huang B et al (2011) Outcomes of head and neck squamous cell carcinoma patients with N3 neck disease treated primarily with chemoradiation versus surgical resection. Laryngoscope 121:1881–1887PubMed

27.

Witek ME, Wieland AM, Chen S, Kennedy TA, Hullett CR, Liang E et al (2017) Outcomes for patients with head and neck squamous cell carcinoma presenting with N3 nodal disease. Cancers Head Neck 2:8CrossRefPubMedPubMedCentral

28.

Zhang L, Jiang N, Shi Y, Li S, Wang P, Zhao Y (2015) Induction chemotherapy with concurrent chemoradiotherapy versus concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of head and neck: a meta-analysis. Sci Rep 5:10798 (Internet) CrossRefPubMedPubMedCentral

29.

Corry J, Peters L, Fisher R et al (2008) N2–N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders—results of Trans Tasman Radiation Oncology Group Study 98.02. Head Neck 30(6):737–742CrossRefPubMed

Titel: Outcome of patients following neo-adjuvant chemotherapy for unresectable cervical nodes in head and neck squamous cell carcinomas
verfasst von: Akshat Malik
Burhanuddin N. Qayyumi
Manish Mair
Hitesh Singhavi
Yash Mathur
Deepa Nair
Sarbani Ghosh-Laskar
Jai Prakash Agrawal
Kumar Prabash
Pankaj Chaturvedi
Publikationsdatum: 17.12.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: European Archives of Oto-Rhino-Laryngology / Ausgabe 2/2019
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-018-5253-4

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Outcome of patients following neo-adjuvant chemotherapy for unresectable cervical nodes in head and neck squamous cell carcinomas